dr. flaherty discusses braf inhibitors in melanoma
Published 5 years ago • 222 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
1:51
dr. flaherty discusses the columbus trial in melanoma
-
2:26
dr. flaherty on the columbus trial updates in melanoma
-
1:11
dr. flaherty on resistance in braf-mutant melanoma
-
1:32
dr. flaherty on the rationale to explore triplet therapy in braf v600e-mutant melanoma
-
1:42
dr. flaherty on second-line therapy for braf-mutant melanoma
-
1:32
dr. liebman on toxicities of braf inhibitors in melanoma
-
8:40
melanoma: braf/mek targeted therapy
-
1:02
dr. flaherty on the tolerability of encorafenib/binimetinib in melanoma
-
29:25
drug combination in melanoma is more better by keith flaherty, md
-
1:28
dr. keith flaherty discusses long-term data from the columbus trial
-
1:06
dr. infante on the future of braf inhibitors in melanoma
-
2:11
dr. keith t. flaherty on 3-year follow-up of combi-d in metastatic melanoma
-
1:09
dr. atkinson discusses braf-mutant metastatic melanoma
-
6:33
treatment of braf-mutant metastatic melanoma
-
9:49
melanoma: nuances of braf/mek combinations in the front line
-
5:31
treating braf-mutated metastatic melanoma
-
9:43
sequencing dual braf-mek inhibition and immunotherapy
-
7:15
dual targeted or immunotherapy for braf-mutant melanoma
-
2:30
dr. keith t. flaherty on the nemo trial in nras-mutant melanoma